Literature DB >> 19324463

[Asthmatic crisis and bronchial hyper-reactivity in a primary care emergency service].

M P Ruiz Durante, A Valiente Miralles.   

Abstract

Mesh：

Year:  2009        PMID： 19324463      PMCID： PMC7021956          DOI： 10.1016/j.aprim.2008.09.013

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  6 in total

1.  [Does experience influence perception of dyspnea?].

Authors:  E Martínez-Moragón; M Perpiñá; A Belloch
Journal:  Arch Bronconeumol       Date:  2006-04       Impact factor: 4.872

2.  Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. MARC investigators. Multicenter Asthma Research Collaboration.

Authors:  C L Emerman; P G Woodruff; R K Cydulka; M A Gibbs; C V Pollack; C A Camargo
Journal:  Chest       Date:  1999-04       Impact factor: 9.410

3.  [Features of patients with bronchial asthma seen at the emergency department of a referral hospital in a semirural area].

Authors:  E Barreiro; M Rubio; F Felisart; J Terrades; R Marcos; J Gea
Journal:  Arch Bronconeumol       Date:  2000-04       Impact factor: 4.872

4.  [Cost and management of asthma attacks treated in primary care (COAX Study)].

Authors:  J Molina París; G Lumbreras García; E Calvo Corbella; K Naberan Toña; M A Lobo Alvarez
Journal:  Aten Primaria       Date:  2005-06-15       Impact factor: 1.137

5.  [Agreement in asthmatics' perception of dyspnea during acute and chronic obstruction].

Authors:  E Martínez-Moragón; M Perpiñá; A Belloch; A de Diego; M E Martínez-Francés
Journal:  Arch Bronconeumol       Date:  2005-07       Impact factor: 4.872

6.  [Cost and management of asthma exacerbations in Spanish hospitals (COAX study in hospital services)].

Authors:  L Borderías Clau; M Zabaleta Murguionda; J A Riesco Miranda; C Pellicer Ciscar; J R Hernández Hernández; T Carrillo Díaz; G Lumbreras García
Journal:  Arch Bronconeumol       Date:  2005-06       Impact factor: 4.872
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.